Actinium Pharmaceuticals, Inc (AMEX: ATNM) last traded at $0.999, down 5.75% on the session. The quote above updates while this page is open; the figures below are drawn from Actinium Pharmaceuticals, Inc’s own filings and are restated only when a new one is published.
Actinium Pharmaceuticals, Inc trades on AMEX under the ticker ATNM. Its market capitalisation is $31.41 million.
Valuation measures for Actinium Pharmaceuticals, Inc, derived from the latest quote and its most recent SEC filing.
| Market cap | $31.41M |
|---|---|
| Enterprise value | $4.79M |
| P/E ratio | 2.85 |
| Price / sales | 349.00 |
| Price / book | 1.04 |
| Beta | 0.63 |
Trailing-twelve-month figures tagged in Actinium Pharmaceuticals, Inc's XBRL filings with the SEC.
| Revenue (TTM) | $90.0K |
|---|---|
| Net income (TTM) | $11.31M |
| EPS (TTM) | $0.350 |
| Return on equity | 37.32% |
| Cash | $36.47M |
Range and volume for ATNM over the past 52 weeks.
| 52-week high | $1.74 |
|---|---|
| 52-week low | $0.735 |
| Volume | 88.2K |
| Average volume | 139.5K |
| Previous close | $1.06 |
Invest a chosen dollar amount in Actinium Pharmaceuticals, Inc with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ATNM.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.